Safe Handling of Hazardous Drugs


Book Description

Guidelines for the safe handling of hazardous wastes have existed for 20 years or more, but with nearly six million health care workers handling these wastes as of 2009, the importance of maintaining safety guidelines has never been greater. The second edition of Safe Handling of Hazardous Drugs, edited by Martha Polovich, provides you with the details and procedures needed to keep safe in the workplace. Youll find information on issues such as drug administration, management of spills, and safety measures as well as details on the adverse effects of hazardous drugs, and evidence of occupational hazardous drugs exposure.




The Chapter 800 Answer Book


Book Description

"Provides explanation of elements of USP Hazardous Drugs' Handling in Healthcare Settings and best practices to comply with the requirements and recommendations of the USP General Chapter"--Pref.




Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice


Book Description

"Oncology nursing is a unique specialty that requires continuous learning to stay up to date on cancer pathophysiology, cutting-edge drugs, and the evidence-based management of cancer and cancer treatment-related toxicities. The Oncology Nursing Society's (ONS's) second edition of Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice provides nurses with the tools to understand how medications are used in cancer treatment, the effect of medication-related toxicities, and evidence-based recommendations to manage and treat these toxicities. This edition features many new cancer therapies approved since the 2019 publication. Each drug is categorized as chemotherapy, hormone, targeted, or immunotherapy agents. Extensive drug tables in the book provide nurses with tips for managing patients receiving these drugs. The expansion of oral antineoplastic therapies, alone or in combination with infusion therapy, requires that nurses review a patient's complete cancer treatment plan and consider the side effects, toxicities, and adherence to oral drugs to ensure patient tolerance and efficacy. This second edition has seen content expanded on the topic of genomics as we move forward in the world of personalized oncology. Health equity is approached with information discussing financial distress, cultural disparities, and health literacy. The latest guidelines and recommendations for treatment, symptom management, and survivorship have been integrated into this new text. This edition features a QR code, provided with the purchase of this book, to download quarterly drug updates. You will see new evidence related to many aspects of cancer nursing care incorporated into this edition, such as hypersensitivity response, safe handling of hazardous drugs, and more. The editors want to thank all of the contributors to this edition who worked tirelessly, despite a pandemic, to make this new edition a reality. This work builds on the knowledge of many generations of oncology nurses and has been used nationally and internationally to guide oncology nursing practice. We are proud to continue to serve oncology nurses worldwide with an essential resource to guide their practice"--




The Use of Drugs in Food Animals


Book Description

The use of drugs in food animal production has resulted in benefits throughout the food industry; however, their use has also raised public health safety concerns. The Use of Drugs in Food Animals provides an overview of why and how drugs are used in the major food-producing animal industriesâ€"poultry, dairy, beef, swine, and aquaculture. The volume discusses the prevalence of human pathogens in foods of animal origin. It also addresses the transfer of resistance in animal microbes to human pathogens and the resulting risk of human disease. The committee offers analysis and insight into these areas: Monitoring of drug residues. The book provides a brief overview of how the FDA and USDA monitor drug residues in foods of animal origin and describes quality assurance programs initiated by the poultry, dairy, beef, and swine industries. Antibiotic resistance. The committee reports what is known about this controversial problem and its potential effect on human health. The volume also looks at how drug use may be minimized with new approaches in genetics, nutrition, and animal management.




Principles and Practice of Screening for Disease


Book Description

The basic principles of early disease detection, practical considerations, including the application of screening procedures in a number of different disease conditions, and, finally, present techniques and possible developments in methodology. Screening for the chronic non-communicable diseases prevalent in the more advanced countries froms the main subject of the report, but the problems facing countries at other stages of development and with different standards and types of medical care are also discussed, and because of this communicable disease detection is also dealth with to some extent.




Biosafety in the Laboratory


Book Description

Biosafety in the Laboratory is a concise set of practical guidelines for handling and disposing of biohazardous material. The consensus of top experts in laboratory safety, this volume provides the information needed for immediate improvement of safety practices. It discusses high- and low-risk biological agents (including the highest-risk materials handled in labs today), presents the "seven basic rules of biosafety," addresses special issues such as the shipping of dangerous materials, covers waste disposal in detail, offers a checklist for administering laboratory safetyâ€"and more.




Risks of Hazardous Wastes


Book Description

Hazardous waste in the environment is one of the most difficult challenges facing our society. The purpose of this book is to provide a background of the many aspects of hazardous waste, from its sources to its consequences, focusing on the risks posed to human health and the environment. It explains the legislation and regulations surrounding hazardous waste; however, the scope of the book is much broader, discussing agents that are released into the environment that might not be classified as hazardous waste under the regulatory system, but nonetheless pose substantial hazards to human health and the environment. It provides a background of some of the major generators of hazardous wastes, explains the pathways by which humans and wildlife are exposed, and includes discussion of the adverse health effects linked to these pollutants. It provides numerous case studies of hazardous waste mismanagement that have led to disastrous consequences, and highlights the deficiencies in science and regulation that have allowed the public to be subjected to myriad potentially hazardous agents. Finally, it provides a discussion of measures that will need to be taken to control society's hazardous waste problem. This book was designed to appeal to a wide range of audiences, including students, professionals, and general readers interested in the topic. - Provides information about sources of and health risks posed by hazardous waste - Explains the legislation and regulations surrounding hazardous waste - Includes numerous case studies of mismanagement, highlights deficiencies in science and regulation and discusses measures to tackle society's hazardous waste problems




Safe Management of Wastes from Health-care Activities


Book Description

This is the second edition of the WHO handbook on the safe, sustainable and affordable management of health-care waste--commonly known as "the Blue Book". The original Blue Book was a comprehensive publication used widely in health-care centers and government agencies to assist in the adoption of national guidance. It also provided support to committed medical directors and managers to make improvements and presented practical information on waste-management techniques for medical staff and waste workers. It has been more than ten years since the first edition of the Blue Book. During the intervening period, the requirements on generators of health-care wastes have evolved and new methods have become available. Consequently, WHO recognized that it was an appropriate time to update the original text. The purpose of the second edition is to expand and update the practical information in the original Blue Book. The new Blue Book is designed to continue to be a source of impartial health-care information and guidance on safe waste-management practices. The editors' intention has been to keep the best of the original publication and supplement it with the latest relevant information. The audience for the Blue Book has expanded. Initially, the publication was intended for those directly involved in the creation and handling of health-care wastes: medical staff, health-care facility directors, ancillary health workers, infection-control officers and waste workers. This is no longer the situation. A wider range of people and organizations now have an active interest in the safe management of health-care wastes: regulators, policy-makers, development organizations, voluntary groups, environmental bodies, environmental health practitioners, advisers, researchers and students. They should also find the new Blue Book of benefit to their activities. Chapters 2 and 3 explain the various types of waste produced from health-care facilities, their typical characteristics and the hazards these wastes pose to patients, staff and the general environment. Chapters 4 and 5 introduce the guiding regulatory principles for developing local or national approaches to tackling health-care waste management and transposing these into practical plans for regions and individual health-care facilities. Specific methods and technologies are described for waste minimization, segregation and treatment of health-care wastes in Chapters 6, 7 and 8. These chapters introduce the basic features of each technology and the operational and environmental characteristics required to be achieved, followed by information on the potential advantages and disadvantages of each system. To reflect concerns about the difficulties of handling health-care wastewaters, Chapter 9 is an expanded chapter with new guidance on the various sources of wastewater and wastewater treatment options for places not connected to central sewerage systems. Further chapters address issues on economics (Chapter 10), occupational safety (Chapter 11), hygiene and infection control (Chapter 12), and staff training and public awareness (Chapter 13). A wider range of information has been incorporated into this edition of the Blue Book, with the addition of two new chapters on health-care waste management in emergencies (Chapter 14) and an overview of the emerging issues of pandemics, drug-resistant pathogens, climate change and technology advances in medical techniques that will have to be accommodated by health-care waste systems in the future (Chapter 15).




Guidelines for the Safe Handling and Disposal of Chemicals Used in the Illlicit Manufacture of Drugs


Book Description

The first United Nations Office on Drugs and Crime (UNODC) Guidelines for the Safe Disposal of Chemicals used in the illicit manufacture of Drugs (STNAR/36) was published in 2006. At the 33rd meeting of the Heads of Law Enforcement Agencies (HONLEA) Asia and Pacific, in Bali, Indonesia in 2010, Member States noted the significant increase in precursor chemicals discovered regionally and expressed concern about the difficulties encountered in storing and disposing of precursor chemicals in a safe and environmentally friendly manner. The present Guidelines reflect the discussions of the experts at the Expert Group Meeting on Safe and Environmentally-Responsible Disposal of Chemicals Used in the Illicit Manufacture of Drugs held in Bangkok, Thailand, from 20 to 22 September 2010, and the elaboration of practical methods for the safe handling and disposal of seized chemicals in situations where a waste management infrastructure may not be available.